The Pre-Filled Syringes East Coast Conference – April 8-9 , Sheraton Boston Hotel, Boston, MA, USA – is an essential platform to discuss the latest issues, engage and network with the leaders in the pre-filled syringe industry.
Dhairya Mehta, Director of Device and Combination Products from Shire, who is one of the Chairs at the event, recently did an interview with the SMi Group where he gave his thoughts on the recent developments in the industry and what the drivers will be over the coming years.
“The Pre-filled syringe market has expanded throughout the drug delivery market with so many new technologies that have morphed into the PFS field”.
“One main progression in the field is how to deliver a large viscous dose to the patient. Pre-filled syringes have made a leap into this with larger containers and better drug delivery systems for improved, easier delivery for patients”.
“Current platforms and syringes are getting increasingly optimized and are no longer stand-alone, with forms such as autoinjectors and pens. Forming the glass is where the science meets the art! A pretty good amount of tolerance is needed when fitting the syringe into an injector and pre-filled syringes are becoming less likely to have defects”.
“There is also a good amount of syringe protection preventing issues such as needle-sticks. There is an increasing amount of attention on the scrutiny and regulations around needle sticks to prevent biohazards …….”
The full interview is available in the Download Centre at http://www.pfsamerica.com
Key sessions over the two days will focus on:
- Updates on new and existing regulatory processes
- Integration of combination products, evaluation of new laws and technology trends
- Human factors and prioritizing patient safety
- Regulatory environment for combination products
- Chemical compatibility and design control strategies
- Product integrity, troubleshooting techniques and outsourcing
- The future of pre-filled syringes
Molly Story, Head of Global Usability Engineering and Risk Management, Sanofi
Linda Ricci, Associate Director for Digital Health, Office of Device Evaluation, FDA
Nicholas Zampa, Senior Engineer, Human Factors and Risk Management, Biogen
John Schalago, Head Devices, EMD Serono
Cedric Gysel, Health Care Solutions Design Manager, Johnson & Johnson Design
Raihan Hossain, Associate Director, Head Drug Device Centre of Excellence, Merck & Co.
3P Innovation | Aptar Pharma | CSS (CONNECTICUT SPRING & STAMPING) | Harro Höfliger | LONSTROFF | MITSUBISHI GAS CHEMICAL | Owen Mumford | Polyplastics | SCHOTT | Steri-Tek | SUMITOMO RUBBER INDUSTRIES |
West Pharmaceutical Services | ZEON | ZwickRoell
Sponsorship, exhibition and branding packages: Alia Malick +44 (0)20 7827 6168 / email@example.com
Delegate enquiries: Kieran Ronaldson on +44 (0) 20 7827 6744 / firstname.lastname@example.org
Media enquiries contact Neill Howard +44 (0) 207 827 6164 email@example.com
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk